Literature DB >> 18787877

Update on the pathogenesis of Parkinson's disease.

Jörg B Schulz1.   

Abstract

Parkinson's disease is a primarily sporadic occurring neurodegenerative disorder of advanced age. However, in the last few years several genes have been identified that lead to a hereditary parkinsonian disorder with autosomal dominant or autosomal recessive inheritance. This includes autosomal dominant mutations in the alpha-synuclein, ubiquitin-C-terminal hydrolase-L1 (UCH-L1) and the leucine-rich repeat kinase (LRRK)2 genes and autosomal recessively inherited mutations in Parkin, PINK1, DJ-1 and the ATP13A2 genes. By taking the biochemical function of these genes and mutations into account, three underlying pathogenetic pathways can be identified: (i) altered protein quality control, (ii) oxidative stress and mitochondrial dysfunction, and (iii) disturbed kinase activity. It remains an open question whether alterations of these pathways lead to different entities of Parkinson's disease or whether they finally converge at a point that is the common pathogenetic denominator of Parkinson's disease. Finally cell death is executed by excitotoxicity, apoptosis and autophagy and appears to be facilitated by neuroinflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787877     DOI: 10.1007/s00415-008-5011-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

1.  The familial Parkinsonism gene LRRK2 regulates neurite process morphology.

Authors:  David MacLeod; Julia Dowman; Rachel Hammond; Thomas Leete; Keiichi Inoue; Asa Abeliovich
Journal:  Neuron       Date:  2006-11-22       Impact factor: 17.173

2.  Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice.

Authors:  L Miguel Martins; Alastair Morrison; Kristina Klupsch; Valentina Fedele; Nicoleta Moisoi; Peter Teismann; Alejandro Abuin; Evelyn Grau; Martin Geppert; George P Livi; Caretha L Creasy; Alison Martin; Iain Hargreaves; Simon J Heales; Hitoshi Okada; Sebastian Brandner; Jörg B Schulz; Tak Mak; Julian Downward
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

3.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

4.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

Review 5.  Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

Authors:  Daniel M Skovronsky; Virginia M-Y Lee; John Q Trojanowski
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

6.  Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging.

Authors:  Felipe Opazo; Antje Krenz; Stephan Heermann; Jörg B Schulz; Björn H Falkenburger
Journal:  J Neurochem       Date:  2008-04-10       Impact factor: 5.372

7.  Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits.

Authors:  Eusebio Lavara-Culebras; Nuria Paricio
Journal:  Gene       Date:  2007-06-29       Impact factor: 3.688

Review 8.  Mitochondrial dysfunction in movement disorders.

Authors:  J B Schulz; M F Beal
Journal:  Curr Opin Neurol       Date:  1994-08       Impact factor: 5.710

9.  Altered proteasomal function in sporadic Parkinson's disease.

Authors:  Kevin St P McNaught; Roger Belizaire; Ole Isacson; Peter Jenner; C Warren Olanow
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

10.  Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.

Authors:  X G Xia; T Harding; M Weller; A Bieneman; J B Uney; J B Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

View more
  17 in total

1.  Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.

Authors:  Zhen-tao Zhang; Xue-bing Cao; Nian Xiong; Hong-cai Wang; Jin-sha Huang; Sheng-gang Sun; Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

2.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

3.  6-OHDA induces cycle reentry and apoptosis of PC12 cells through activation of ERK1/2 signaling pathway.

Authors:  Zhentao Zhang; Tao Wang; Xuebing Cao; Shenggang Sun; Lan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

4.  Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

Authors:  Frank Soldner; Dirk Hockemeyer; Caroline Beard; Qing Gao; George W Bell; Elizabeth G Cook; Gunnar Hargus; Alexandra Blak; Oliver Cooper; Maisam Mitalipova; Ole Isacson; Rudolf Jaenisch
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

Review 5.  Basic science in Parkinson's disease: its impact on clinical practice.

Authors:  Jörg B Schulz; Manfred Gerlach; Gabriele Gille; Wilfried Kuhn; Martina Müngersdorf; Peter Riederer; Martin Südmeyer; Albert Ludolph
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

6.  Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.

Authors:  Endre Czeiter; Stefania Mondello; Noemi Kovacs; Janos Sandor; Andrea Gabrielli; Kara Schmid; Frank Tortella; Kevin K W Wang; Ronald L Hayes; Pal Barzo; Erzsebet Ezer; Tamas Doczi; Andras Buki
Journal:  J Neurotrauma       Date:  2012-04-30       Impact factor: 5.269

7.  The parkin mutant phenotype in the fly is largely rescued by metal-responsive transcription factor (MTF-1).

Authors:  Nidhi Saini; Oleg Georgiev; Walter Schaffner
Journal:  Mol Cell Biol       Date:  2011-03-07       Impact factor: 4.272

Review 8.  Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review.

Authors:  Aswir Abd Rashed; Ahmad Zuhairi Abd Rahman; Devi Nair Gunasegavan Rathi
Journal:  Molecules       Date:  2021-02-19       Impact factor: 4.411

Review 9.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

10.  Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus.

Authors:  Luke T Stewart; Anas U Khan; Kai Wang; Diana Pizarro; Sandipan Pati; Susan C Buckingham; Michelle L Olsen; John C Chatham; Lori L McMahon
Journal:  J Neurosci       Date:  2017-07-31       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.